{"id":"W3017326650","doi":"10.1016/j.jacc.2020.04.031","title":"COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up","year":2020,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2939,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital; Thrombosis and Atherosclerosis Research Institute; Hamilton Health Sciences; Population Health Research Institute; McMaster University","funders":"National Institutes of Health; LEO Pharma; Sanofi; Bayer HealthCare; European Society of Cardiology; National Center for Advancing Translational Sciences; Agence Nationale de la Recherche; Bristol-Myers Squibb; AstraZeneca; Daiichi-Sankyo; National Heart, Lung, and Blood Institute; Pfizer; Irving Medical Center, Columbia University","keywords":"Medicine; Antithrombotic; Intensive care medicine; Disease; Thrombosis; Pandemic; Venous thrombosis; Coronavirus disease 2019 (COVID-19); Coronavirus; Internal medicine; Infectious disease (medical specialty)","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}